About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Restructures

October 12, 2015

Click here to read more

Post navigation

Phosphagenics Begins its Animal Health and Nutrition Program

Phosphagenics Signs Development Agreement with tesa Labtec for TPM/Oxymorphone Patch

Related Posts

Observational study testing enhanced CBD formulation

December 22, 2020February 23, 2021

Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan

January 31, 2017

Phosphagenics Initiates Grower/Finisher Pig Study

December 3, 2015

Recent Posts

Media | Avecho featured on 9 News
June 23, 2025
New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025
Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.